23andMe sees independent board members resign en masse– Brit Commerce
23andMeThe personal genomics company, 23andMe, went public in early 2021 through a merger with a blank-check company that valued it at $3.5 billion. Then its fortunes began to sink. Declining interest in DNA kits (23andMe’s main product) was one of the factors driving it down. So was last year’s news that hackers stole ancestry data […]
23andMe sees independent board members resign en masse– Brit Commerce Read More »